BioWorld MedTech

July 18, 2019

Paragon Biosciences unveils Qlarity Imaging to advance Quantx system

Chicago-based Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which will focus on further developing Quantx, an FDA-cleared, computer-aided breast cancer diagnosis system. Read More

Endotronix enrolls first patient in CE mark trial for pulmonary artery pressure sensor

Casetabs secures $3M for surgical coordination tech

Industry seeks clarity in FDA's draft rule on radiological health regs

To treat or not to treat? Machine learning has answers

Regulatory front

Financings

Daily M&A

Appointments and advancements

Other news to note

Product regulatory actions for July 17, 2019

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan. 13, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 13, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

BioWorld

Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...